{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T14:53:19Z","timestamp":1781275999937,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015374","name":"Xiangnan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012249","name":"Jiangxi University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2020243"],"award-info":[{"award-number":["2020243"]}],"id":[{"id":"10.13039\/501100012249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.clinre.2026.102763","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T17:16:55Z","timestamp":1768324615000},"page":"102763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics and risk factors of drug-induced hepatotoxicity in cancer patients following repeated chemotherapy cycles"],"prefix":"10.1016","volume":"50","author":[{"given":"Qunxiang","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinre.2026.102763_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clinre.2026.102763_bib0002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/bs.enz.2022.10.002","article-title":"Inhibition of DNA synthesis and cancer therapies","volume":"52","author":"Tamanoi","year":"2022","journal-title":"Enzymes"},{"issue":"10","key":"10.1016\/j.clinre.2026.102763_bib0003","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/annonc\/mdw271","article-title":"Chemotherapy remains an essential element of personalized care for persons with lung cancers","volume":"27","author":"Hellmann","year":"2016","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.clinre.2026.102763_bib0004","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejim.2021.10.035","article-title":"Drug-induced liver injury: pathogenesis, epidemiology, clinical features, and practical management","volume":"97","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.clinre.2026.102763_bib0005","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: drug-induced liver injury","volume":"70","year":"2019","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2026.102763_bib0006","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1055\/s-0034-1375957","article-title":"Drug-induced liver injury due to cancer chemotherapeutic agents","volume":"34","author":"Bahirwani","year":"2014","journal-title":"Semin Liver Dis"},{"issue":"7","key":"10.1016\/j.clinre.2026.102763_bib0007","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1053\/j.gastro.2010.04.001","article-title":"Risk factors for idiosyncratic drug-induced liver injury","volume":"138","author":"Chalasani","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102763_bib0008","article-title":"The toxic effects of polychemotherapy onto the liver are accelerated by the upregulated MDR of lymphosarcoma","volume":"2012","author":"Sen\u2019kova","year":"2012","journal-title":"ISRN Oncol"},{"issue":"2","key":"10.1016\/j.clinre.2026.102763_bib0009","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/toxsci\/kfz156","article-title":"Drug-drug combinations can enhance toxicity as shown by monocyte-derived hepatocyte-like cells from patients with idiosyncratic drug-induced liver injury","volume":"171","author":"Benesic","year":"2019","journal-title":"Toxicol Sci Off J Soc Toxicol"},{"issue":"3","key":"10.1016\/j.clinre.2026.102763_bib0010","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2026.102763_bib0011","doi-asserted-by":"crossref","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","article-title":"Practice parameters committee of the american college of gastroenterology. ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury","volume":"116","author":"Chalasani","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2026.102763_bib0012","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/CCO.0000000000000592","article-title":"Chemotherapy remains a cornerstone in the treatment of nonsmall cell lung cancer","volume":"32","author":"Pirker","year":"2020","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.clinre.2026.102763_bib0013","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.critrevonc.2018.06.019","article-title":"The use of SAMe in chemotherapy-induced liver injury","volume":"130","author":"Vincenzi","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.clinre.2026.102763_bib0014","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clinre.2026.102763_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121071","article-title":"The prevalence of drug-drug interactions in cancer therapy and the clinical outcomes","volume":"310","author":"Alnaim","year":"2022","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.clinre.2026.102763_bib0016","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/tcrm.1.2.151.62914","article-title":"Clinical implications of changes in hepatic drug metabolism in older people","volume":"1","author":"Hilmer","year":"2005","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"10.1016\/j.clinre.2026.102763_bib0017","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s12072-024-10679-1","article-title":"Age-related differences in drug-induced liver injury: a retrospective single-center study from a large liver disease specialty hospital in China, 2002-2022","volume":"18","author":"Yu","year":"2024","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.clinre.2026.102763_bib0018","doi-asserted-by":"crossref","first-page":"8041","DOI":"10.1038\/s41467-023-43064-x","article-title":"Binge-pattern alcohol consumption and genetic risk as determinants of alcohol-related liver disease","volume":"14","author":"Ding","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.clinre.2026.102763_bib0019","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3138\/canlivj-2021-0018","article-title":"Hepatotoxicity during legacy cancer chemotherapy in patients infected with hepatitis C virus: a retrospective cohort study","volume":"5","author":"Szpakowski","year":"2022","journal-title":"Can Liver J"},{"issue":"5","key":"10.1016\/j.clinre.2026.102763_bib0020","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019013","article-title":"Safety and efficacy of immune checkpoint inhibitors in patients with HBV\/HCV infection and advanced-stage cancer: a systematic review","volume":"99","author":"Pu","year":"2020","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.clinre.2026.102763_bib0021","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cld.2013.07.010","article-title":"Chemotherapy-induced hepatotoxicity","volume":"17","author":"Thatishetty","year":"2013","journal-title":"Clin Liver Dis."},{"key":"10.1016\/j.clinre.2026.102763_bib0022","first-page":"75","article-title":"Drug-induced liver injury in obesity and nonalcoholic fatty liver disease","volume":"85","author":"Allard","year":"2019","journal-title":"Adv Pharmacol San Diego Calif"},{"issue":"9","key":"10.1016\/j.clinre.2026.102763_bib0023","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/jcph.2059","article-title":"Drug-Drug Interactions and Disease Status Are Associated With Irinotecan-Induced Hepatotoxicity: a Cross-Sectional Study in Shanghai","volume":"62","author":"Li","year":"2022","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.clinre.2026.102763_bib0024","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17425255.2021.1867105","article-title":"Multi-factorial pharmacokinetic interactions: unraveling complexities in precision drug therapy","volume":"17","author":"Bechtold","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"10.1016\/j.clinre.2026.102763_bib0025","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1080\/01480545.2021.1945004","article-title":"Glabridin attenuates paracetamol-induced liver injury in mice via CYP2E1-mediated inhibition of oxidative stress","volume":"45","author":"Bhatt","year":"2022","journal-title":"Drug Chem Toxicol"},{"issue":"Suppl 1","key":"10.1016\/j.clinre.2026.102763_bib0026","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S2210-7401(12)70015-3","article-title":"Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action","volume":"36","author":"Poupon","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2026.102763_bib0027","article-title":"Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: a prospective study in a tertiary care teaching hospital","volume":"26","author":"Ramasubbu","year":"2021","journal-title":"Cancer Treat Res Commun"},{"issue":"4","key":"10.1016\/j.clinre.2026.102763_bib0028","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5588\/ijtld.14.0579","article-title":"Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease","volume":"19","author":"Chu","year":"2015","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"10.1016\/j.clinre.2026.102763_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3192351","article-title":"Prophylactic therapy of silymarin (Milk Thistle) on antituberculosis drug-induced liver injury: a meta-analysis of randomized controlled trials","author":"Tao","year":"2019","journal-title":"Can J Gastroenterol Hepatol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T23:21:51Z","timestamp":1774048911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740126000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2210740126000100"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102763","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and risk factors of drug-induced hepatotoxicity in cancer patients following repeated chemotherapy cycles","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102763"}}